PD09-02 ANTI-ADENOVIRAL ANTIBODY LEVELS PREDICT NADOFARAGENE FIRADENOVEC RESPONSE IN BCG-UNRESPONSIVE NMIBC: RESULTS FROM A PHASE 3 TRIAL

Overview of attention for article published in The Journal of Urology, September 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 news story.

Increased Antibody Titers Could be Predictive of Durability of Nadofaragene Firadenovec in BCG-Unresponsive Non–Muscle Invasive Bladder Cancer

Cancer Network, 24 Oct 2021

In patients with bacillus Calmette-Guérun–unresponsive non-muscle invasive bladder cancer who are being treated with…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.